상위피인용논문
전남대학교
Don-Kyu Kim ‡ 1, Dongryeol Ryu § 1, Minseob Koh ¶ 2, Min-Woo Lee §, Donghyun Lim ‖, Min-Jung Kim §, Yong-Hoon Kim **, Won-Jea Cho ‡‡, Chul-Ho Lee **, Seung Bum Park ¶ ‖, Seung-Hoi Koo §, Hueng-Sik Choi ‡ §§
‡National Creative Research Initiatives Center for Nuclear Receptor Signals, Hormone Research Center, School of Biological Sciences and Technology, Chonnam National University, Gwangju 500-757, Republic of Korea
‡‡College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea
§Department of Molecular Cell Biology and Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, 300 Chunchun-dong, Jangan-gu, Suwon, Gyeonggi-do 440-746, Republic of Korea
¶Departments of Chemistry, Seoul National University, Seoul 151-747, Republic of Korea
‖Departments of Biophysics and Chemical Biology, College of Natural Sciences, Seoul National University, Seoul 151-747, Republic of Korea
**Korea Research Institute of Bioscience and Biotechnology, Daejeon 305-806, Republic of Korea
§§Research Institute of Medical Sciences, Department of Biomedical Sciences, Chonnam National University Medical School, Gwangju 501-746, Republic of Korea
1Both authors contributed equally to this work.
2Supported by a Brain Korea 21 Program fellowship award and a Seoul Science fellowship award.
*Corresponding authors: Seung Bum Park, Seung-Hoi Koo or Hueng-Sik Choi
Abstract
Background: Dysregulation of glucose homeostasis is often associated with insulin resistance and diabetes.
Results: Hepatic ERRγ expression is increased by fasting-dependent activation of the CREB-CRTC2 pathway, which leads to the induction of hepatic gluconeogenesis.
Conclusion: Orphan nuclear receptor ERRγ is a novel transcriptional regulator of hepatic gluconeogenesis.
Significance: An ERRγ inverse agonist could be a new potential therapeutic approach for the treatment of type 2 diabetes.
논문정보
소속기관 논문보기
관련분야 논문보기